Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Forming agent for gate insulating film of thin film transistor
Case for electronic device
Control unit of a ride level control system, and ride level control system
Group of amino substituted benzoyl derivatives and their preparation and their use
Fuel cell system with mechanical check valve
Satellite fleet deployment
Integrated emergency medical database system
  Randomly Featured Patents
Regulator with segmented body
Cleaning cloth and cleaning apparatus
Apparatus for relieving the symptoms of deep vein thrombosis
Photochemically or thermally polymerizable mixtures
Method of manufacturing a wiring board
Box stacker
Digital to analog conversion devices
Slanted inline filter
Pad painter
Selectively absorbent mask printing process